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S U M M A R Y
We report the ﬁrst case of rickettsialpox caused by Rickettsia akari in the Netherlands. The diagnosis was
suspected based on clinical grounds and was conﬁrmed by Western blot analysis with cross-adsorption.
Because the arthropod vector (Liponyssoides sanguineus) is ubiquitous, we suspect that the disease is
under-diagnosed in non-endemic areas.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Rickettsioses are emerging zoonoses caused by intracellular
bacteria of the order Rickettsia. Rickettsia akari is the causative
agent of rickettsialpox, which was ﬁrst described in 1946 in New
York City. The disease was named rickettsialpox because of its
rickettsial etiology and a clinical resemblance to chickenpox.1
Rickettsialpox has been described worldwide and is transmitted by
the house mite Liponyssoides sanguineus. Renewed interest in this
infectious disease has occurred in recent years. We present a case
of rickettsialpox that occurred in Northern Europe.
2. Case report
A 51-year-old man presented with skin lesions, fever, and chills
during July 2009. The patient had received oral ﬂucloxacillin
without improvement of symptoms. He had traveled from his city
of residence of The Hague (Netherlands) to Brussels (Belgium),
where he had stayed in a hotel for several days, and had returned
from his visit to Brussels 10 days before the onset of symptoms. He
denied contact with animals, drug abuse, and recent or previous* Corresponding author. Tel.: +33 491 385 517; fax: +33 491 387 772.
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did not appear ill, and all of his vital signs were normal, including
body temperature. A 1.5 cm wide black eschar, surrounded by a
faint red area was present in the vicinity of his left elbow (Figure 1),
accompanied by a subtle lymphangitis of the left upper arm (not
visible in the ﬁgure). In addition, there was a 2 cm wide vesicular
lesion adjacent to the eschar (Figure 1), as well as multiple small
vesicular lesions on the patient’s chest and back.
Laboratory studies revealed an elevated erythrocyte sedimen-
tation rate of 4 mm/h, a hemoglobin level of 9.2 g/dl, a normal
leukocyte count with normal differentiation, a normal platelet
count, and normal liver function. A diagnosis of rickettsialpox was
suspected because of the typical triad of an eschar, a vesicular
lesion, and lymphangitis. The patient was treated with 200 mg
doxycycline per day for 10 days (treatment began on the day of
presentation), which resulted in complete resolution of the skin
lesions and other symptoms.
Serum samples taken early (on the day of presentation) and late
(2 weeks later) in the infection were tested at the Unite´ des
Rickettsies (Marseilles, France) using a multiple-antigen immu-
noﬂuorescence assay.2 At the French national reference center, we
use a panel of antigens corresponding to the geographical zone
where each patient has been. These particular antigens correspond
to rickettsial species found in Europe. For the early serum sample,
the antibody titers for the spotted fever group Rickettsia (SFG)ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Left elbow region of the patient with the typical eschar, a vesicular lesion,
and, vaguely, also the lymphangitis leading up to the left upper arm.
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aeschlimannii, and Rickettsia massiliae) were 32 for IgG and were
negative for IgM, and antibody titers were negative for typhus group
rickettsiae. For the late serum sample, the antibody titers for the SFG
were 64 for IgG and 16 for IgM, and the antibody titers remained
negative for typhus group. DNA was extracted from the serum using
the QIAamp Tissue Kit (Qiagen, Hilden, Germany) in accordance with
the manufacturer’s instructions. Both sera were tested using a real-
time PCR with a probe that allowed for screening of SFG Rickettsia3
and with a speciﬁc R. akari probe (R_akari_1_F 50-GCATGCGTCC-
CAAGTTCATA-30; R_akari_1_R 50-ACGAACGGCGGTACTCCTAA-30;
R_akari_1_P 6-FAM-TCCGTGCCCGCCGAGGAATA-TAMRA). Both re-
al-time PCRs were negative. A Western blot with cross-adsorption
was performed,4which showed that R. akari was the causative agent
of the disease (Supplementary Material). Western blot analysis is
more sensitive and allows for an earlier diagnosis relative to the
indirect immunoﬂuorescent assay. It is particularly useful for
determining the involved Rickettsia species, either by the detection
of speciﬁc antigens, or more frequently by cross-adsorption. Cross-
adsorption is performed by mixing the patient’s sample with several
antigens that correspond to the different species that are suspected
of being the etiological agent. Homologous and heterologous
antibodies are adsorbed and removed by incubation with the
causative bacteria, while only homologous antibodies are removed
by adsorption with cross-reacting bacteria.4
3. Discussion
Rickettsialpox is a worldwide mite-borne zoonosis caused by R.
akari. Conﬁrmed cases of rickettsialpox and serological surveys
have been reported in America, Asia, Africa, and Europe.1,5,6
Rickettsialpox has been associated with homelessness and
intravenous drug abuse.6,7 The arthropod vector is the mouse
mite (Liponyssoides sanguineus), whose principal rodent host is the
house mouse (Mus musculus), which is ubiquitously distributed
throughout the world. Humans are not a regular component of the
natural circulation of R. akari.1 The disease probably has a
worldwide distribution, but is under-diagnosed, particularly in
the tropics. Rickettsialpox has been described in patients of all
ages, and equally among males and females.1The incubation period lasts 6 to 15 days. Clinically, an eschar at
the site of inoculation with eventual regional adenopathy occurs
ﬁrst, but can be missing.5 The eschar usually starts as a painless
vesicle and represents the site of inoculation. After a week, other
symptoms develop, such as fever, malaise, headache, sweats,
myalgia, chills, and, ﬁnally, a maculopapular rash and secondary
papulovesicular lesions. The exanthema consists of 2- to-10-mm-
diameter, discrete, erythematous maculopapules distributed over
the extremities, abdomen, back, chest, and face, but rarely on the
palms and soles. After 2 to 3 days, some lesions become indurated
and develop a small vesicle containing cloudy ﬂuid at their apices.
Vesicular lesions on buccal mucous membranes are found in 17–
26% of patients.1 Rickettsialpox is among the rare rickettsioses
causing vesicular eruption, which include Queensland tick typhus
and African tick bite fever.8 Rickettsialpox is generally benign and
self-limiting, but neurological symptoms such as photophobia,
vertigo, pain on movement of the eyes, and nuchal rigidity may be
severe enough to warrant lumbar puncture.1 Cases of hepatitis
have recently been reported.9
Rickettsialpox is the only vesicular rickettsiosis that has been
identiﬁed in Europe where it has been reported only twice, in
Ukraine and Croatia.1 In cases where patients have not traveled to
New York City, where the disease is most commonly reported,
clinical suspicion is necessary to make the diagnosis. This could
explain why the disease has not been widely reported, even
though both the vector and the host are ubiquitous. Only
specialized laboratory techniques can discriminate between the
Rickettsia species. In suspected cases, the diagnosis can be
conﬁrmed either by PCR from a biopsy of the eschar or by speciﬁc
serology. In 2001, intense public and clinician scrutiny regarding
eschar-associated illnesses followed the intentional release of
Bacillus anthracis in the USA,6 which resulted in a noticeable
increase in the number of reported cases of rickettsialpox in New
York City.
The subject gave informed consent to the work.
Conﬂict of interest: No conﬂict of interest to declare.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ijid.2011.11.009.
References
1. Paddock CD, Eremeeva ME. Rickettsialpox. In: Raoult D, Parola P, editors.
Rickettsial diseases. New York: Informa Healthcare; 2007. p. 63–86.
2. Rolain JM, Gouriet F, Brouqui P, Larrey D, Janbon F, Vene S, et al. Concomitant or
consecutive infection with Coxiella burnetii and tickborne diseases. Clin Infect Dis
2005;40:82–8.
3. Socolovsch C, Mediannikov O, Sokhna C, Tall A, Diatta G, Bassene H, et al.
Rickettsia felis-associated uneruptive fever, Senegal. Emerg Infect Dis 2010;16:
1140–2.
4. La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches
to the diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997;35:
2715–27.
5. Zavala-Castro JE, Zavala-Velazquez JE, Peniche-Lara GF, Sulu Uicab JE. Human
rickettsialpox, southeastern Mexico. Emerg Infect Dis 2009;15:1665–7.
6. Paddock CD, Koss T, Eremeeva ME, Dasch GA, Zaki SR, Sumner JW. Isolation of
Rickettsia akari from eschars of patients with rickettsialpox. Am J Trop Med Hyg
2006;75:732–8.
7. Brouqui P, Raoult D. Arthropod-borne diseases in homeless. Ann N Y Acad Sci
2006;1078:223–35.
8. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world:
emerging diseases challenging old concepts. Clin Microbiol Rev 2005;18:719–56.
9. Madison G, Kim-Schluger L, Braverman S, Nicholson WL, Wormser GP. Hepatitis
in association with rickettsialpox. Vector Borne Zoonotic Dis 2008;8:111–5.
